韩国艰难梭菌感染实验室诊断首次全国调查
2015年5月韩国对临床微生物实验室进行CDI诊断方法自愿在线调查,66家实验室回复,其中9家未开展检测。剩余57家中,毒素AB EIA、NAAT和培养的使用率分别为89.5%、64.9%和64.9%,40.4%同时开展三种方法,仅1家使用GDH检测。
要点
- 毒素AB EIA是韩国最常用的CDI检测方法,使用率达89.5%。
- NAAT和培养使用率均为64.9%,40.4%实验室同时开展三种方法。
- 仅1家实验室使用谷氨酸脱氢酶检测,9家仅用毒素AB EIA。
核心结论
- 韩国CDI实验室诊断以毒素AB EIA为主,NAAT和培养也较常用,GDH检测极少使用。
研究设计与样本
- 2015年5月对韩国临床微生物实验室进行自愿在线调查,共66家实验室回复,包括61家医院和5家商业实验室。
主要发现
- 9家实验室未开展CDI检测,剩余57家中毒素AB EIA、NAAT和培养的使用率分别为51家(89.5%)、37家(64.9%)和37家(64.9%)。
- 23家(40.4%)实验室同时开展三种检测方法,仅1家使用GDH检测,9家仅用毒素AB EIA。
- 毒素AB EIA、NAAT和培养的月检测标本量中位数(范围)分别为160(50-2,060)、70(7-720)和130(9-750)。
临床怎么用
- 调查结果可为韩国CDI实验室诊断现状提供基础数据,并指导改进实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In May 2015, we conducted a voluntary online survey on laboratory diagnostic assays for Clostridium difficile infection (CDI) across clinical microbiology laboratories in Korea. Responses were obtained from 66 laboratories, including 61 hospitals and five commercial laboratories. Among them, nine laboratories reported having not conducted CDI assays. The toxin AB enzyme immunoassay (toxin AB EIA), nucleic acid amplification test (NAAT), and C. difficile culture, alone or in combination with other assays, were used in 51 (89.5%), 37 (64.9%), and 37 (64.9%) of the remaining 57 laboratories, respectively, and 23 (40.4%) of the laboratories performed all three assays. Only one laboratory used the glutamate dehydrogenase assay. Nine laboratories used the toxin AB EIA as a stand-alone assay. The median (range) of examined specimens in one month for the toxin AB EIA, NAAT, and C. difficile culture was 160 (50-2,060), 70 (7-720), and 130 (9-750), respectively. These findings serve as valuable basic data regarding the current status of laboratory diagnosis of CDI in Korea, offering guidance for improved implementation.
引用
- Chung HS, Park JS, Shin BM, et al. Laboratory Diagnosis of Clostridium difficile Infection in Korea: The First National Survey. Ann Lab Med. 2019. PMID: 30623624. doi:10.3343/alm.2019.39.3.317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。